Application of NSAIDs in the treatment of pulmonary diseases- a comparative study of the therapeutic & the adverse impacts

Application of NSAIDs in the treatment of pulmonary diseases- a comparative study of the therapeutic & the adverse impacts

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2019.

Библиографические подробности
Главный автор:	Rahman, Farhana
Другие авторы:	Afrose, Afrina
Формат:	Диссертация
Язык:	English
Опубликовано:	Brac University 2021
Предметы:	NSAIDs Pulmonary diseases Pulmonary administration Therapeutic effectiveness Adverse impacts Better & safe treatment opportunities Lungs > Diseases
Online-ссылка:	http://hdl.handle.net/10361/14396

Схожие документы

Different approaches in the treatment of obstructive pulmonary diseases
по: Kabir, Eva Rahman, и др.
Опубликовано: (2016)

Pulmonary patient compliance among different types of inhaler dosage forms in Mohakhali, Dhaka
по: Rithin, Rafia Islam
Опубликовано: (2022)

Patients' compliance in pulmonary drug delivery systems in Mirpur
по: Faruqe, Abdullah Al
Опубликовано: (2021)

Prevalence and risk factors of chronic obstructive pulmonary disease in Bangladesh: A systematic review
по: Sutradhar, Ipsita, и др.
Опубликовано: (2022)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
по: Shabnam, Musharrat
Опубликовано: (2018)

Evaluation of three immunological tests for the diagnosis of pulmonary tuberculosis in a rural endemic area of Bangladesh
по: Islam, Mohammad Tariqul, и др.
Опубликовано: (2016)

Occupational Pulmonary Tuberculosis among BRAC Community Health Workers of Trishal, Bangladesh
по: Karim, Fazlul, и др.
Опубликовано: (2019)

Therapeutic and adverse effects of SSRIs
по: Rahman, Imtiazur
Опубликовано: (2018)

Lost in care pathway: a qualitative investigation on the health system delay of extra pulmonary tuberculosis patients in Bangladesh
по: Sarker, Malabika, и др.
Опубликовано: (2018)

A short review on additional therapeutic effects and adverse effects of sedative and hypnotic drugs
по: Tisha, Sadia Sultana
Опубликовано: (2021)

A brief survey on the effect of smoke of different sources on COPD patients
по: Nawal, Nusrat
Опубликовано: (2021)

Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
по: Onanna, Kazi
Опубликовано: (2024)

Prevalence of Tuberculosis and associated factors in Sylhet, Bangladesh
по: Ara, Effat
Опубликовано: (2021)

The adverse impact on the project by facade package
по: BUCG
Опубликовано: (2023)

Barriers to oral and inhaled drug delivery: a review
по: Kamal, Farhana
Опубликовано: (2023)

An overview on Covid-19 and invention of its treatment by drugs
по: Nawer, Anika
Опубликовано: (2022)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
по: Rahman, Tasnim
Опубликовано: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
по: Islam, Md. Irfath
Опубликовано: (2023)

Potential of liposomes for the treatment of lung cancer- a review
по: Mim, Shanzida
Опубликовано: (2023)

A review on recent advances in drugs for lung cancer treatment
по: Noor, Fouzia
Опубликовано: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
по: Afsana, Nourin
Опубликовано: (2022)

Treatment regimens of urinary bladder adenocarcinoma
по: Tarafder, Ayndrila
Опубликовано: (2024)

A review on the pathophysiology and potential drugs for Covid-19
по: Modak, Srijani
Опубликовано: (2022)

Use of nano-emulsion for delivery of NSAID
по: Khatun, Hafiza
Опубликовано: (2021)

Treatment options of Parkinson’s disease: How far we are from the cure?
по: Afreen, Nuraia
Опубликовано: (2021)

A comprehensive review on drug repurposing in cancer treatment
по: Sarkar, Onusree
Опубликовано: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
по: Flora, Sanzida Alam
Опубликовано: (2024)

Implications of unusual non-coding RNAs in human diseases
по: Ahmed, Tazkia
Опубликовано: (2021)

Exploring the potential of organic molecules in the treatment of covid-19
по: Mondol, Winifred Claire
Опубликовано: (2024)

Stem cells as therapeutic carrier in cancer treatment
по: Anika, Mysha Yeasmin
Опубликовано: (2022)

A review on targeted therapies for lung cancer
по: Ashraf, Anushey
Опубликовано: (2023)

Antimicrobial peptides in skin diseases
по: Pinkey, Monika Tabassum
Опубликовано: (2022)

Biologics and Biosimilars as Treatment Options for Psoriasis
по: Moya, Amena Khatun
Опубликовано: (2023)

Medications used for covid-19 treatment and a comparison of their mechanism of action and therapeutic efficacy
по: Sultana, Sadia
Опубликовано: (2023)

Vitamin C and the common cold /
по: Pauling, Linus, 1901-1994
Опубликовано: (1970)

Evaluation of wound healing using a combination therapy of NSAID and an antioxidant on mice model
по: Biswas, Raisa Prapti
Опубликовано: (2018)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
по: F. S. Amaral, André, и др.
Опубликовано: (2017)

Evaluation of endometriosis risk factors, symptoms, and clinical treatments in Bangladesh: a cross-sectional study
по: Afrose, Afsana
Опубликовано: (2024)

PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment
по: Lubaba, Anikah
Опубликовано: (2024)

Antimicrobial peptides in the treatment of dermatosis
по: Hussain, Sumaya Binty
Опубликовано: (2024)